Structure Therapeutics (GPCR) Stock Chart & Stock Price History $19.06 -0.18 (-0.91%) As of 01:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Structure Therapeutics Stock Price Performance The Structure Therapeutics (GPCR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 57.33%, with a year-to-date return of -29.74%. In the past month, the stock has decreased 7.37%, reflecting recent market activity. As of the latest close, Structure Therapeutics traded at $19.23 with a market cap of $1.10 billion and volume of 1.10 million shares. Receive GPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Structure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.24%1 Month Performance-7.37%3 Month Performance+2.83%Year-To-Date Performance-29.74%1 Year Performance-57.33% GPCR Stock Chart for Wednesday, July, 16, 2025 GPCR Chart by TradingView Structure Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$19.57$19.23-1.74%$20.21$19.231.10 million shs$1.10 billion07/14/2025$19.01$19.57+2.95%$19.84$18.75956,816 shs$1.12 billion07/11/2025$18.90$19.01+0.58%$19.89$18.52685,699 shs$1.09 billion07/10/2025$19.10$18.90-1.05%$19.30$18.50558,853 shs$1.08 billion07/09/2025$18.74$19.10+1.92%$19.40$18.741.01 million shs$1.10 billion07/08/2025$18.73$18.74+0.05%$19.20$18.64650,287 shs$1.07 billion07/07/2025$20.62$18.73-9.16%$20.61$18.72726,173 shs$1.07 billion07/04/2025$20.62$20.62$20.81$19.83372,490 shs$1.18 billion07/03/2025$20.44$20.62+0.88%$20.81$19.83372,490 shs$1.18 billion07/02/2025$20.51$20.44-0.34%$21.40$20.35487,348 shs$1.17 billion Get the Latest News and Ratings for GPCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Structure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$20.74$20.51-1.11%$21.40$20.35425,852 shs$1.18 billion06/30/2025$21.08$20.74-1.61%$21.25$20.65357,768 shs$1.19 billion06/27/2025$21.08$21.08$21.68$20.87382,930 shs$1.21 billion06/26/2025$21.79$21.08-3.26%$22.11$20.70550,991 shs$1.21 billion06/25/2025$22.38$21.79-2.64%$22.42$21.02704,601 shs$1.25 billion06/24/2025$22.10$22.38+1.27%$23.67$21.641.06 million shs$1.28 billion06/23/2025$21.73$22.10+1.70%$22.89$20.911.71 million shs$1.27 billion06/20/2025$21.62$21.73+0.51%$22.33$21.04749,888 shs$1.25 billion06/19/2025$21.62$21.62$21.78$20.71639,625 shs$1.24 billion06/18/2025$20.97$21.62+3.10%$21.78$20.71639,625 shs$1.24 billion06/17/2025$20.57$20.97+1.94%$21.48$20.42630,065 shs$1.20 billion06/16/2025$21.68$20.57-5.12%$21.97$20.56599,945 shs$1.18 billion Related Companies Metsera Stock Price Chart ADMA Biologics Stock Price Chart Krystal Biotech Stock Price Chart Akero Therapeutics Stock Price Chart Avidity Biosciences Stock Price Chart PTC Therapeutics Stock Price Chart Arcellx Stock Price Chart Merus Stock Price Chart Zai Lab Stock Price Chart Scholar Rock Stock Price Chart Receive GPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Structure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GPCR) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Structure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
